Plant Health Care Share Discussion Threads

[ntbb] 19/8/2019 21:05

Riddle, from what they have achieved, cash burns is high with these products but look on the bright side, they have product that is somthing the big giants havnt achieved!

[ntbb] 19/8/2019 21:02

From last results




"The Company's cash reserves remain sufficient to take us to cash positive in 2020."

Inside information

[riddlerone] 19/8/2019 18:39

Cash Burn still high and find it hard to trust the management not to raise funds if the opportunity arises .Keep pumping boys but get ready for a suprise...its happened here before with the same narrative

"With the completion of the $10 million placement in August 2016, we are now confident of delivering first revenues from our PREtec peptide platforms and of bringing our Commercial business to profit, within our existing cash resources"

And then

27 February 2018

Plant Health Care plc

Proposed Placing and Subscription

GBP5.0 million

Go back through this thread but more importantly the previous thread and you will see the over promise and under performance of the past.

[ny boy] 19/8/2019 15:59

Plenty of potential upside then ntbb

Onwards and upwards!

[ntbb] 19/8/2019 13:56

I find it amazing that this company is valued about 13 million including cash and operating in billions of dollars market!

[ntbb] 19/8/2019 10:41

It's worth keeping in mind the recent deal with Wilbur would bring in more new customers,

This new agreement with Wilbur-Ellis will substantially increase the number of growers introduced to the product.

[ntbb] 19/8/2019 09:04

And I doubt very much a majors would let this product go into compititors hand wit result like this


August 2019

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

Progress with PREtec field trials in Brazil

Plant Health Care(R) , a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to provide the following update in relation to the 2018/19 field trials of the PREtec peptide PHC279 for the control of Asian Soybean Rust (ASR) a potentially devastating disease that regularly affects soybean yields in Brazil.

Highlights:

- PHC279 significantly improved ASR control of foliar fungicide programmes, even in fields facing heavy disease pressure.


   -     Up to 16% increase of soybean yields when PHC279 was applied as a seed treatment.

- Up to 45% increase in the effectiveness of foliar fungicide treatments when seeds had been treated with PHC279.

- Plant Health Care is now moving to register and manufacture PHC279 for launch into soybeans in Brazil as a seed treatment for ASR control.

Brazil is the world's largest exporter of soybeans, with some 36 million hectares (89 million acres) planted in 2018. One of the challenges of producing soybeans in Brazil is ASR, which is a potentially devastating disease. Growers spent $2.1 billion in 2017 on soybean fungicides in Brazil.

[ntbb] 19/8/2019 08:29

    Plant Health Care has signed an agreement with Wilbur-Ellis, one of the largest U.S. agriculture distributors, for distribution of Harpin aß (Employ) in the U.S.

-     Wilbur-Ellis will market Employ into the specialty crops market, which is estimated to be over 7 million acres in the U.S.

 

[ntbb] 19/8/2019 08:18

Should hear alot of deals announcement soon

[ny boy] 16/8/2019 16:19

I’m in for a run back to 15p

[ntbb] 16/8/2019 15:30

Buywell are you talking about your self?

[buywell3] 16/8/2019 12:16

buywell told you guys

Swine Fever Is Killing Vast Numbers Of Pigs In China
NPR-15 Aug 2019
Half of the world's pigs live in China — or at least they did before the ... enough to push down global prices for soybeans,

[ntbb] 16/8/2019 12:02

That is a massive 45% improvement fighting disease and yields of 16%



independent trials, carried out by PLANTEC, a major contract research organisation in Brazil, PHC279 significantly improved ASR control of foliar fungicide programmes, even in fields facing heavy disease pressure. Disease control was improved by up to 45% when PHC279 was applied as a seed treatment. In addition, yields of soybeans were increased by up to 16% when compared with foliar fungicide programs alone. These results provide increasing support for the acceptance of PHC279 as a compelling tool to combat ASR.

[ntbb] 16/8/2019 11:34

I'm still confident of this ending blue, just look at the last 2 rns, this company is worth hundreds of millions

[ntbb] 16/8/2019 10:07

Iv just added close to 9p buy, I'm quite confident 9p should be gone pretty soon

[ntbb] 16/8/2019 08:52

Buster that makes phc even more valuable, this is ripe for m&a

[busterposh2] 16/8/2019 08:42

"If fungus resistance to carboxamide spreads across the country, Brazil soybeans may lose as much as 30% of their output," That's because there's no substitute for carboxamide available to farmers, according to Andre Savino, for Switzerland-based Syngenta.

[ntbb] 16/8/2019 08:39

And just in Brazil alone, 2.1 billion dollar

Brazil is the world's largest exporter of soybeans, with some 36 million hectares (89 million acres) planted in 2018. One of the challenges of producing soybeans in Brazil is ASR, which is a potentially devastating disease. Growers spent $2.1 billion in 2017 on soybean fungicides in Brazil.

[busterposh2] 16/8/2019 08:30

Almost 56% of domestic fungicide spending last year was for soybeans, according to Sindiveg, a pesticide industry group that includes global producers such as Syngenta AG, Bayer AG and BASF SE.

[kaur70] 16/8/2019 08:15

Quiet rerate bubbling

[ntbb] 16/8/2019 08:09

Even with the last rns, phc has fantastic future


Highlights:

-     Plant Health Care has signed an agreement with Wilbur-Ellis, one of the largest U.S. agriculture distributors, for distribution of Harpin aß (Employ) in the U.S.

-     Wilbur-Ellis will market Employ into the specialty crops market, which is estimated to be over 7 million acres in the U.S.

 

Wilbur-Ellis, a recognized leader in precision agriculture technology and the marketing and distribution of plant protection, seed and nutritional products in the US market, has agreed to be the exclusive distributor for Employ, containing Plant Health Care's Harpin aß technology, for applications to specialty crops (fruits and vegetables) in the U.S. Specialty crops comprise more than 7 million acres in the U.S.

 

Harpin aß works by triggering the plant's own self defense systems, in a manner similar to vaccinations in humans. The plant responds with improved vigor, healthy growth, heightened defense response and, ultimately, increased yield. Being a biological product, Harpin aß has a very favorable human and environmental safety profile.

 

Employ provides benefits for the growers of fruits and vegetables through increased yield and quality.  Employ was recognized as Best New Biological Product at the Agrow Awards in November 2018. This new agreement with Wilbur-Ellis will substantially increase the number of growers introduced to the product.

 

Jesse Rosales, Wilbur-Ellis Branded Technologies Portfolio Manager commented:

 

"The addition of Employ to our branded offerings is a meaningful step forward to becoming a distribution market leader in the biological solutions space. We are very excited about growing this product in key specialty crops regions like Washington, Oregon, Michigan and the broader Northeastern U.S."

 

[ntbb] 15/8/2019 18:13

On AIM, Plant Health Careclosed 51% higher after the agriculture-focused biological products maker announced it will commercialise the PHC279 plant fungal treatment product in Brazil following successful trials. Plant Health Care conducted field trials on PHC279 to establish its effectiveness in dealing with asian soybean rust, a fungal disease that negatively impacts soybean yields in Brazil. Following application of the peptide treatment - derived from natural proteins - Plant Health Care reported a 16% increase in soybean yield even in areas facing "heavy disease pressure